The Benefits of Clinical Trials for Triple Negative Breast Cancer

Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Minetta C. Liu, MD

Professor and Research Chair, Division of Medical Oncology, Department of Oncology, Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Medical Director, Office of Specialty Collaborations and Contracts, Co-Leader, Genomics in Action Strategic Priority, Center for Individualized Medicine, Mayo Clinic

Elizabeth Jane Cathcart-Rake, MD

Staff Physician, Hematology/Oncology, Saint Luke’s Cancer Specialist in Breast Cancer, Saint Luke’s Cancer Institute

Hayley Dinerman, JD

Co-Founder and Executive Director, Triple Negative Breast Cancer Foundation®

Ricki Fairley

Vice President, Strategic Partnerships and National Programs, Sisters Network^® Inc. – A National African American Breast Cancer Survivorship Network

Lauren Chatalian, MSW

Women and Children's Program Coordinator, CancerCare